Does the LDL Receptor Play a Role in the Risk of Developing Type 2 Diabetes?

Share this content:
Does the LDL Receptor Play a Role in the Risk of Developing Type 2 Diabetes?
Does the LDL Receptor Play a Role in the Risk of Developing Type 2 Diabetes?
Over the last 5 years, major randomized clinical trials and meta-analyses of these trials have indicated that statin therapy, which inhibits 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), is associated with a modestly higher risk of developing diabetes in a dose-dependent fashion.
READ FULL ARTICLE From Jamanetwork
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »